BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15282162)

  • 1. Cell autonomy of the mouse claw paw mutation.
    Darbas A; Jaegle M; Walbeehm E; van den Burg H; Driegen S; Broos L; Uyl M; Visser P; Grosveld F; Meijer D
    Dev Biol; 2004 Aug; 272(2):470-82. PubMed ID: 15282162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation.
    Zorick TS; Syroid DE; Arroyo E; Scherer SS; Lemke G
    Mol Cell Neurosci; 1996; 8(2-3):129-45. PubMed ID: 8918830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation.
    Nickols JC; Valentine W; Kanwal S; Carter BD
    Nat Neurosci; 2003 Feb; 6(2):161-7. PubMed ID: 12514737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The claw paw mutation reveals a role for Lgi4 in peripheral nerve development.
    Bermingham JR; Shearin H; Pennington J; O'Moore J; Jaegle M; Driegen S; van Zon A; Darbas A; Ozkaynak E; Ryu EJ; Milbrandt J; Meijer D
    Nat Neurosci; 2006 Jan; 9(1):76-84. PubMed ID: 16341215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells.
    Parkinson DB; Dickinson S; Bhaskaran A; Kinsella MT; Brophy PJ; Sherman DL; Sharghi-Namini S; Duran Alonso MB; Mirsky R; Jessen KR
    Mol Cell Neurosci; 2003 May; 23(1):13-27. PubMed ID: 12799134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel method for studying myelination in vivo reveals that EDTA is a potent inhibitor of myelin protein and mRNA expression during development of the rat sciatic nerve.
    Meintanis S; Thomaidou D; Jessen KR; Mirsky R; Matsas R
    Glia; 2004 Nov; 48(2):132-44. PubMed ID: 15378656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protooncogene Ski controls Schwann cell proliferation and myelination.
    Atanasoski S; Notterpek L; Lee HY; Castagner F; Young P; Ehrengruber MU; Meijer D; Sommer L; Stavnezer E; Colmenares C; Suter U
    Neuron; 2004 Aug; 43(4):499-511. PubMed ID: 15312649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse mutation claw paw: forelimb deformity and delayed myelination throughout the peripheral nervous system.
    Henry EW; Eicher EM; Sidman RL
    J Hered; 1991; 82(4):287-94. PubMed ID: 1652607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway.
    Fischer S; Weishaupt A; Troppmair J; Martini R
    Glia; 2008 Jun; 56(8):836-43. PubMed ID: 18383340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The raft-associated protein MAL is required for maintenance of proper axon--glia interactions in the central nervous system.
    Schaeren-Wiemers N; Bonnet A; Erb M; Erne B; Bartsch U; Kern F; Mantei N; Sherman D; Suter U
    J Cell Biol; 2004 Aug; 166(5):731-42. PubMed ID: 15337780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury.
    Tomita K; Kubo T; Matsuda K; Fujiwara T; Yano K; Winograd JM; Tohyama M; Hosokawa K
    Glia; 2007 Aug; 55(11):1199-208. PubMed ID: 17600367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schwann cells genetically engineered to express PSA show enhanced migratory potential without impairment of their myelinating ability in vitro.
    Lavdas AA; Franceschini I; Dubois-Dalcq M; Matsas R
    Glia; 2006 Jun; 53(8):868-78. PubMed ID: 16598779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal neuregulin-1 regulates myelin sheath thickness.
    Michailov GV; Sereda MW; Brinkmann BG; Fischer TM; Haug B; Birchmeier C; Role L; Lai C; Schwab MH; Nave KA
    Science; 2004 Apr; 304(5671):700-3. PubMed ID: 15044753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a dominant connexin32 mutant in myelinating Schwann cells.
    Jeng LJ; Balice-Gordon RJ; Messing A; Fischbeck KH; Scherer SS
    Mol Cell Neurosci; 2006 Jul; 32(3):283-98. PubMed ID: 16790356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture.
    Liu N; Varma S; Shooter EM; Tolwani RJ
    J Neurosci Res; 2005 Feb; 79(3):310-7. PubMed ID: 15605381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of connexin expression during mouse Schwann cell development identifies connexin29 as a novel marker for the transition of neural crest to precursor cells.
    Li J; Habbes HW; Eiberger J; Willecke K; Dermietzel R; Meier C
    Glia; 2007 Jan; 55(1):93-103. PubMed ID: 17024657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reelin is transiently expressed in the peripheral nerve during development and is upregulated following nerve crush.
    Panteri R; Mey J; Zhelyaznik N; D'Altocolle A; Del Fà A; Gangitano C; Marino R; Lorenzetto E; Buffelli M; Keller F
    Mol Cell Neurosci; 2006; 32(1-2):133-42. PubMed ID: 16697663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the mouse mutation claw paw on myelination and nodal frequency in sciatic nerves.
    Koszowski AG; Owens GC; Levinson SR
    J Neurosci; 1998 Aug; 18(15):5859-68. PubMed ID: 9671673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-myc downstream-regulated gene 1 expression in injured sciatic nerves.
    Hirata K; Masuda K; Morikawa W; He JW; Kuraoka A; Kuwano M; Kawabuchi M
    Glia; 2004 Sep; 47(4):325-34. PubMed ID: 15293230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.